---
phase: 06-findings-domains
plan: 03
subsystem: execution
tags: [ts-domain, pe-domain, trial-summary, fda-compliance, pydantic]

requires:
  - phase: 06-findings-domains (plan 01)
    provides: TRANSPOSE handler and SUPPQUAL generator foundation
  - phase: 04.1-fda-compliance
    provides: Execution pipeline, pattern handlers, sequence generation
provides:
  - TSConfig model for trial summary configuration
  - build_ts_domain function for TS domain DataFrame generation
  - validate_ts_completeness for FDA-mandatory parameter checking
  - PE domain execution test proving minimal Findings-class pattern
affects: [06-findings-domains remaining plans, 07-validation]

tech-stack:
  added: []
  patterns: [config-driven domain builder, key-value TS structure]

key-files:
  created:
    - src/astraea/models/trial_design.py
    - src/astraea/execution/trial_summary.py
    - tests/unit/execution/test_trial_summary.py
    - tests/integration/execution/test_pe_execution.py
  modified: []

key-decisions:
  - "TSParameter auto-uppercases tsparmcd and validates max 8 chars"
  - "FDA_REQUIRED_PARAMS is 7 codes (SSTDTC derived from DM, not config)"
  - "build_ts_domain derives SSTDTC/SENDTC from DM DataFrame when available"

patterns-established:
  - "Config-driven domain builder: TSConfig -> build_ts_domain -> DataFrame (no LLM, no executor)"
  - "Key-value domain pattern: one row per parameter with TSSEQ sequencing"

duration: 4min
completed: 2026-02-28
---

# Phase 6 Plan 3: TS Domain Builder and PE Execution Summary

**Config-driven TS domain builder with FDA-mandatory parameter validation and PE Findings-class execution test**

## Performance

- **Duration:** 4 min
- **Started:** 2026-02-28T01:35:46Z
- **Completed:** 2026-02-28T01:39:34Z
- **Tasks:** 2
- **Files created:** 4

## Accomplishments

- TSConfig Pydantic model with all FDA-required and optional trial summary parameters
- build_ts_domain produces key-value TS DataFrame with TSSEQ sequencing and date derivation from DM
- validate_ts_completeness checks 7 FDA-mandatory TSPARMCD codes with empty-value detection
- PE domain execution tests prove minimal Findings-class pattern (performed flag + date only)

## Task Commits

Each task was committed atomically:

1. **Task 1: TS domain builder with TSConfig model** - `d8ff769` (feat)
2. **Task 2: PE domain execution test** - `f40a0d7` (test)

## Files Created/Modified

- `src/astraea/models/trial_design.py` - TSParameter and TSConfig Pydantic models for trial summary configuration
- `src/astraea/execution/trial_summary.py` - build_ts_domain, validate_ts_completeness, FDA_REQUIRED_PARAMS
- `tests/unit/execution/test_trial_summary.py` - 20 unit tests covering build, dates, optionals, validation, model constraints
- `tests/integration/execution/test_pe_execution.py` - 5 integration tests for PE domain execution with synthetic data

## Decisions Made

- TSParameter.tsparmcd auto-uppercases input and validates max 8 chars (XPT constraint)
- FDA_REQUIRED_PARAMS contains 7 codes; SSTDTC is derived from DM RFSTDTC rather than provided in config
- SENDTC derived from max RFENDTC only when that column exists in DM
- PE test uses ASSIGN for PETESTCD/PETEST since this study only records "was PE performed" (no body system detail)

## Deviations from Plan

None - plan executed exactly as written.

## Issues Encountered

None.

## User Setup Required

None - no external service configuration required.

## Next Phase Readiness

- TS domain builder ready for integration into full study pipeline
- PE execution pattern validated for minimal Findings domains
- Remaining Phase 6 plans: VS/LB/EG transpose execution, QS domain
- Full test suite: 1099 passed, 86 skipped

---
*Phase: 06-findings-domains*
*Completed: 2026-02-28*
